# DEIT

> DEIT is a VC fund backing Software, Health Care and Medical Device. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Apr 2021
- Lead investor: 50%
- Last updated: Aug 2026

DEIT is a VC fund focused on Software and Health Care. Dongeun Information Technology

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $100k–$240k |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 1 | 50% |
| Health Care | 1 | 50% |
| Medical Device | 1 | 50% |
| Machine Learning | 1 | 50% |
| Artificial Intelligence | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PMX Inc. | PMX is a medical technology company that delivers personalized health insights using a breakthrough AI-assisted imaging platform. Founded in April 2021, PMX has developed an automated multi-modality imaging platform, called MediOMX, to build end-to-end applications that measure the vital organs and tissues of the body for universal care andwellness. PMX product pipeline is designed such that it does not distract the existing radiological workflow, instead, it improves the current one by connecting the chain of image acquisition, processing, and reporting system. Our quick, accurate, and cost-effective solutions are highly beneficial to all stakeholders in the imaging ecosystem including patients, referring clinicians, radiologists, and administration. Using this end-to-end platform, we have built 3 main use cases as follows: - 15 minutes dementia screening using brain MRI; - Full body MRI screening for assessing an athlete's body and performing injury risk analysis; - Chest CT screening for various lung diseases particularly infiltrating pneumonia such as COVID-19 | $100K | Seed | Apr 29, 2021 | http://www.pmx-inc.com |
| PMX Inc. | PMX is a medical technology company that delivers personalized health insights using a breakthrough AI-assisted imaging platform. Founded in April 2021, PMX has developed an automated multi-modality imaging platform, called MediOMX, to build end-to-end applications that measure the vital organs and tissues of the body for universal care andwellness. PMX product pipeline is designed such that it does not distract the existing radiological workflow, instead, it improves the current one by connecting the chain of image acquisition, processing, and reporting system. Our quick, accurate, and cost-effective solutions are highly beneficial to all stakeholders in the imaging ecosystem including patients, referring clinicians, radiologists, and administration. Using this end-to-end platform, we have built 3 main use cases as follows: - 15 minutes dementia screening using brain MRI; - Full body MRI screening for assessing an athlete's body and performing injury risk analysis; - Chest CT screening for various lung diseases particularly infiltrating pneumonia such as COVID-19 | $240K | Seed | Apr 01, 2021 | http://www.pmx-inc.com |

2 of 2 investments shown.

## Co-investors
- [TIPS Program](https://shizune.co/investors/profile/tips-program) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Medical Device Investors in South Korea](https://shizune.co/investors/medical-device-investors-south-korea)
- [Medical Device VC Funds in South Korea](https://shizune.co/investors/medical-device-vc-funds-south-korea)
- [Health Care Investors in South Korea](https://shizune.co/investors/health-care-investors-south-korea)
- [Artificial intelligence Investors in South Korea](https://shizune.co/investors/artificial-intelligence-investors-south-korea)

## FAQ

### What does DEIT invest in?

DEIT invests primarily in Software, Health Care and Medical Device startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is DEIT's check size?

DEIT typically joins rounds of $100k–$240k at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds DEIT participates in.

### When did DEIT last invest?

The most recent investment recorded for DEIT closed in Apr 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co